{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:47:02Z","timestamp":1753890422475,"version":"3.41.2"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Human transcriptome can undergo RNA mis-splicing due to spliceopathies contributing to the increasing number of genetic diseases including muscular dystrophy (MD), Alzheimer disease (AD), Huntington disease (HD), myelodysplastic syndromes (MDS). Intron retention (IR) is a major inducer of spliceopathies where two or more introns remain in the final mature mRNA and account for many intronic expansion diseases. Potential removal of such introns for therapeutic purposes can be feasible when utilizing bioinformatics, catalytic RNAs, and nano-drug delivery systems. Overcoming delivery challenges of catalytic RNAs was discussed in this review as a future perspective highlighting the significance of utilizing synthetic biology in addition to high throughput deep sequencing and computational approaches for the treatment of mis-spliced transcripts.<\/jats:p>","DOI":"10.3389\/fbioe.2023.1244377","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:35:11Z","timestamp":1700210111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unleashing the potential of catalytic RNAs to combat mis-spliced transcripts"],"prefix":"10.3389","volume":"11","author":[{"given":"Bashayer A.","family":"Khalifah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shareefa A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nnano.2010.160","article-title":"In vitro assembly of cubic RNA-based scaffolds designed in silico","volume":"5","author":"Afonin","year":"2010","journal-title":"Nat. Nanotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ymeth.2013.10.013","article-title":"Computational and experimental characterization of RNA cubic nanoscaffolds","volume":"67","author":"Afonin","year":"2014","journal-title":"Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1021\/nl302302e","article-title":"Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs","volume":"12","author":"Afonin","year":"2012","journal-title":"Nano Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/cpt.1802","article-title":"Pharmacokinetics and pharmacodynamics of the small interfering ribonucleic acid, givosiran, in patients with acute hepatic porphyria","volume":"108","author":"Agarwal","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/d1bm00235j","article-title":"Catalogue of self-targeting nano-medical inventions to accelerate clinical trials","volume":"9","author":"Alsudir","year":"2021","journal-title":"Biomaterials Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1261\/rna.051888.115","article-title":"Increased efficiency of evolved group i intron spliceozymes by decreased side product formation","volume":"21","author":"Amini","year":"2015","journal-title":"RNA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e101932","DOI":"10.1371\/journal.pone.0101932","article-title":"Spliceozymes: ribozymes that remove introns from pre-mRNAs in trans","volume":"9","author":"Amini","year":"2014","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1261\/rna.2299306","article-title":"Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction","volume":"12","author":"An","year":"2006","journal-title":"RNA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13353-018-0444-7","article-title":"Splicing mutations in human genetic disorders: examples, detection, and confirmation","volume":"59","author":"Anna","year":"2018","journal-title":"J. Appl. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1186\/1471-2164-16-S2-S9","article-title":"IRcall and IRclassifier: two methods for flexible detection of intron retention events from RNA-Seq data","volume":"16","author":"Bai","year":"2015","journal-title":"BMC Genomics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/s0618-8278(19)30142-2","article-title":"GS-14-ENVISION, a phase 3 study to evaluate efficacy and safety of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1, in acute hepatic porphyria patients","volume":"70","author":"Balwani","year":"2019","journal-title":"J. Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/nejmoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/sb500270h","article-title":"Conditional control of mammalian gene expression by tetracycline-dependent hammerhead ribozymes","volume":"4","author":"Beilstein","year":"2015","journal-title":"ACS Synth. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/biot.201300498","article-title":"RNA aptamers as genetic control devices: the potential of riboswitches as synthetic elements for regulating gene expression","volume":"10","author":"Berens","year":"2015","journal-title":"Biotechnol. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","article-title":"Roles and mechanisms of alternative splicing in cancer\u2014implications for care","volume":"17","author":"Bonnal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1101\/gad.247361.114","article-title":"Detained introns are a novel, widespread class of post-transcriptionally spliced introns","volume":"29","author":"Boutz","year":"2015","journal-title":"Genes. Dev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e2002623","DOI":"10.1371\/journal.pbio.2002623","article-title":"Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation","volume":"15","author":"Brady","year":"2017","journal-title":"PLoS Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1101\/gr.177790.114","article-title":"Widespread intron retention in mammals functionally tunes transcriptomes","volume":"24","author":"Braunschweig","year":"2014","journal-title":"Genome Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.molcel.2011.04.018","article-title":"Identification of a MicroRNA that activates gene expression by repressing nonsense-mediated RNA decay","volume":"42","author":"Bruno","year":"2011","journal-title":"Mol. Cell."},{"key":"B20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/wrna.1203","article-title":"Cytoplasmic intron retention, function, splicing, and the sentinel RNA hypothesis","volume":"5","author":"Buckley","year":"2014","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.nano.2016.12.018","article-title":"Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology","volume":"13","author":"Bui","year":"2017","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.actbio.2013.07.021","article-title":"Design and application of multifunctional DNA nanocarriers for therapeutic delivery","volume":"10","author":"Charoenphol","year":"2014","journal-title":"Acta Biomater."},{"key":"B23","doi-asserted-by":"publisher","first-page":"eabg4910","DOI":"10.1126\/sciadv.abg4910","article-title":"Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing","volume":"7","author":"Chemello","year":"2021","journal-title":"Sci. Adv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41434-018-0040-9","article-title":"Scaffold-mediated delivery for non-viral mRNA vaccines","volume":"25","author":"Chen","year":"2018","journal-title":"Gene Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","article-title":"Targeting RNA structures with small molecules","volume":"21","author":"Childs-Disney","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8316","DOI":"10.1021\/nn3030223","article-title":"Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing","volume":"6","author":"Conde","year":"2012","journal-title":"ACS Nano"},{"key":"B27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40291-019-00438-6","article-title":"Leading RNA interference therapeutics Part 2: silencing delta-aminolevulinic acid synthase 1, with a focus on givosiran","volume":"24","author":"de Paula Brand\u00e3o","year":"2020","journal-title":"Mol. Diagnosis Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41573-019-0042-3","article-title":"Targeting mRNA processing as an anticancer strategy","volume":"19","author":"Desterro","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-015-0168-9","article-title":"Widespread intron retention diversifies most cancer transcriptomes","volume":"7","author":"Dvinge","year":"2015","journal-title":"Genome Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1182\/blood-2016-01-692764","article-title":"A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages","volume":"127","author":"Edwards","year":"2016","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"114039","DOI":"10.1016\/j.bcp.2020.114039","article-title":"Targeting the spliceosome machinery: a new therapeutic axis in cancer?","volume":"189","author":"Eymin","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13046-020-01616-9","article-title":"Hypoxia-induced alternative splicing: the 11th hallmark of cancer","volume":"39","author":"Farina","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1261\/rna.5123504","article-title":"Detection and evaluation of intron retention events in the human transcriptome","volume":"10","author":"Galante","year":"2004","journal-title":"RNA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1172\/JCI200319462","article-title":"Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing","volume":"112","author":"Garcia-Blanco","year":"2003","journal-title":"J. Clin. Investigation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/nejmoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ncomms1328","article-title":"Intron retention in the Drosophila melanogaster Rieske iron sulphur protein gene generated a new protein","volume":"2","author":"Gontijo","year":"2011","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1631","DOI":"10.1002\/wrna.1631","article-title":"Intron retention and its impact on gene expression and protein diversity: a review and a practical guide","volume":"12","author":"Grabski","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/molecules25010204","article-title":"Gold nanoparticles in conjunction with nucleic acids as a modern molecular system for cellular delivery","volume":"25","author":"Graczyk","year":"2020","journal-title":"Molecules"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0168-9525(00)02176-4","article-title":"Alternative splicing: increasing diversity in the proteomic world","volume":"17","author":"Graveley","year":"2001","journal-title":"Trends Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.molcel.2012.08.018","article-title":"Extensive degradation of RNA precursors by the exosome in wild-type cells","volume":"48","author":"Gudipati","year":"2012","journal-title":"Mol. Cell."},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijpharm.2016.05.027","article-title":"Bioconjugated gold nanoparticles enhance cellular uptake: a proof of concept study for siRNA delivery in prostate cancer cells","volume":"509","author":"Guo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1007\/s12274-015-0829-4","article-title":"Biomimetic gold nanocomplexes for gene knockdown: will gold deliver dividends for small interfering RNA nanomedicines?","volume":"8","author":"Guo","year":"2015","journal-title":"Nano Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/wrna.1158","article-title":"Targeting RNA splicing for disease therapy","volume":"4","author":"Havens","year":"2013","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1021\/ja4098862","article-title":"Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells","volume":"136","author":"He","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1700634","DOI":"10.1002\/biot.201700634","article-title":"An RNA origami octahedron with intrinsic siRNAs for potent gene knockdown","volume":"14","author":"H\u00f8iberg","year":"2019","journal-title":"Biotechnol. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1101\/gad.7.2.320","article-title":"Stages in the second reaction of pre-mRNA splicing: the final step is ATP independent","volume":"7","author":"Horowitz","year":"1993","journal-title":"Genes. and Dev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1701153","DOI":"10.1002\/adhm.201701153","article-title":"DNA nanostructure-based systems for intelligent delivery of therapeutic oligonucleotides","volume":"7","author":"Hu","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3724\/sp.j.1206.2010.00061","article-title":"Progress in the research of LASP-1: progress in the research of LASP-1","volume":"37","author":"Huang","year":"2019","journal-title":"Prog. Biochem. Biophysics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/nar\/gkw010","article-title":"Mechanism and regulation of the nonsense-mediated decay pathway","volume":"44","author":"Hug","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbrc.2011.09.147","article-title":"Rapid delivery of small interfering RNA by biosurfactant MEL-A-containing liposomes","volume":"414","author":"Inoh","year":"2011","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00439-017-1791-x","article-title":"Intron retention as a component of regulated gene expression programs","volume":"136","author":"Jacob","year":"2017","journal-title":"Hum. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature06495","article-title":"Translational control of intron splicing in eukaryotes","volume":"451","author":"Jaillon","year":"2008","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.bbagrm.2013.03.002","article-title":"Regulation of nonsense-mediated mRNA decay: implications for physiology and disease","volume":"1829","author":"Karam","year":"2013","journal-title":"Biochimica Biophysica Acta - Gene Regul. Mech."},{"key":"B57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.copbio.2019.11.019","article-title":"RNA and protein-based nanodevices for mammalian post-transcriptional circuits","volume":"63","author":"Kawasaki","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/jor.24321","article-title":"Scaffold-based delivery of nucleic acid therapeutics for enhanced bone and cartilage repair","volume":"37","author":"Kelly","year":"2019","journal-title":"J. Orthop. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41467-021-22009-2","article-title":"CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells","volume":"12","author":"Kluesner","year":"2021","journal-title":"Nat. Commun."},{"key":"B60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00439-021-02409-6","article-title":"Differential fates of introns in gene expression due to global alternative splicing","volume":"141","author":"Kumari","year":"2022","journal-title":"Hum. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nnano.2012.73","article-title":"Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery","volume":"7","author":"Lee","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ceb.2005.03.002","article-title":"Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells","volume":"17","author":"Lejeune","year":"2005","journal-title":"Curr. Opin. Cell. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12864-020-6541-0","article-title":"IREAD: a tool for intron retention detection from RNA-seq data","volume":"21","author":"Li","year":"2020","journal-title":"BMC Genomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1261\/rna.058040.116","article-title":"Inhibition of nonsense-mediated RNA decay by ER stress","volume":"23","author":"Li","year":"2017","journal-title":"RNA"},{"key":"B65","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/thno.35568","article-title":"RNA nanotechnology-mediated cancer immunotherapy","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"8933","DOI":"10.1093\/nar\/gkw560","article-title":"The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators","volume":"44","author":"Llorian","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1134\/S0006297916070063","article-title":"Viral vectors for gene therapy: current state and clinical perspectives","volume":"81","author":"Lukashev","year":"2016","journal-title":"Biochem. Mosc."},{"key":"B68","doi-asserted-by":"publisher","first-page":"503128","DOI":"10.1016\/j.mrgentox.2019.503128","article-title":"pH-induced variations in the TK1 gene model","volume":"849","author":"Massonneau","year":"2020","journal-title":"Mutat. Res. - Genet. Toxicol. Environ. Mutagen."},{"key":"B69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1083\/jcb.201611002","article-title":"Mammalian synthetic biology for studying the cell","volume":"216","author":"Mathur","year":"2017","journal-title":"J. Cell. Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.neuron.2016.11.032","article-title":"Targeted intron retention and excision for rapid gene regulation in response to neuronal activity","volume":"92","author":"Mauger","year":"2016","journal-title":"Neuron"},{"key":"B71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13059-017-1184-4","article-title":"IRFinder: assessing the impact of intron retention on mammalian gene expression","volume":"18","author":"Middleton","year":"2017","journal-title":"Genome Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s13346-021-00911-y","article-title":"Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine","volume":"11","author":"Milane","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng0102-13","article-title":"A genomic view of alternative splicing","volume":"30","author":"Modrek","year":"2002","journal-title":"Nat. Genet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jconrel.2020.06.038","article-title":"In vivo gene delivery mediated by non-viral vectors for cancer therapy","volume":"325","author":"Mohammadinejad","year":"2020","journal-title":"J. Control. Release"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/nar\/gkz753","article-title":"Robust gene expression control in human cells with a novel universal TetR aptamer splicing module","volume":"47","author":"Mol","year":"2019","journal-title":"Nucleic acids Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"11497","DOI":"10.1093\/nar\/gkz1068","article-title":"The changing paradigm of intron retention: regulation, ramifications and recipes","volume":"47","author":"Monteuuis","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"868664","DOI":"10.3389\/fonc.2022.868664","article-title":"Therapeutic targeting of alternative splicing: a new frontier in cancer treatment","volume":"12","author":"Murphy","year":"2022","journal-title":"Front. Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/nsmb.2944","article-title":"Using synthetic RNAs as scaffolds and regulators","volume":"22","author":"Myhrvold","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.devcel.2017.03.003","article-title":"An orchestrated intron retention program in meiosis controls timely usage of transcripts during germ cell differentiation","volume":"41","author":"Naro","year":"2017","journal-title":"Dev. Cell."},{"key":"B80","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.semcdb.2017.08.053","article-title":"Beyond quality control: the role of nonsense-mediated mRNA decay (NMD) in regulating gene expression","volume":"75","author":"Nasif","year":"2018","journal-title":"Seminars Cell. Dev. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.copbio.2018.11.006","article-title":"RNA nanostructures and scaffolds for biotechnology applications","volume":"58","author":"Ohno","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1021\/acs.jmedchem.7b01147","article-title":"Facile synthesis, geometry, and 2\u2032-substituent-dependent in vivo activity of 5\u2032-(E)- and 5\u2032-(Z)-Vinylphosphonate-Modified siRNA conjugates","volume":"61","author":"Parmar","year":"2018","journal-title":"J. Med. Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1091\/mbc.E09-01-0028","article-title":"Analysis of Dom34 and its function in No-Go decay","volume":"20","author":"Passos","year":"2009","journal-title":"Mol. Biol. Cell."},{"key":"B84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1021\/acschembio.7b00437","article-title":"Site-selective RNA splicing nanozyme: DNAzyme and RtcB conjugates on a gold nanoparticle","volume":"13","author":"Petree","year":"2018","journal-title":"ACS Chem. Biol."},{"article-title":"Keep me around: intron retention detection and analysis","year":"2015","author":"Pimentel","key":"B85"},{"key":"B86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jconrel.2009.12.006","article-title":"The forthcoming applications of gold nanoparticles in drug and gene delivery systems","volume":"149","author":"Pissuwan","year":"2011","journal-title":"J. Control. Release"},{"key":"B87","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.sbi.2020.06.011","article-title":"New insights into no-go, non-stop and nonsense-mediated mRNA decay complexes","volume":"65","author":"Powers","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1038\/s41467-019-10562-w","article-title":"Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes","volume":"10","author":"Qiu","year":"2019","journal-title":"Nat. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1101\/gr.473902","article-title":"Large-scale proteomic analysis of the human spliceosome","volume":"12","author":"Rappsilber","year":"2002","journal-title":"Genome Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nano.2008.06.001","article-title":"Drug delivery of siRNA therapeutics: potentials and limits of nanosystems","volume":"5","author":"Reischl","year":"2009","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1002\/wrna.1470","article-title":"Intron retention in viruses and cellular genes: detention, border controls and passports","volume":"9","author":"Rekosh","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"B93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"B94","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S1525-0016(02)00063-1","article-title":"Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing","volume":"7","author":"Ryu","year":"2003","journal-title":"Mol. Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"9493","DOI":"10.1093\/nar\/gku617","article-title":"In vivo co-localization of enzymes on RNA scaffolds increases metabolic production in a geometrically dependent manner","volume":"42","author":"Sachdeva","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/nejmoa1807838","article-title":"Phase 1 trial of an RNA interference therapy for acute intermittent porphyria","volume":"380","author":"Sardh","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrg.2015.3","article-title":"RNA mis-splicing in disease","volume":"17","author":"Scotti","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1364\/boe.9.000518","article-title":"Imaging of pre-mRNA splicing in living subjects using a genetically encoded luciferase reporter","volume":"9","author":"Shi","year":"2018","journal-title":"Biomed. Opt. Express"},{"key":"B99","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1016\/j.febslet.2006.08.021","article-title":"Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme","volume":"580","author":"Song","year":"2006","journal-title":"FEBS Lett."},{"key":"B100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.copbio.2019.11.008","article-title":"Aptamers in RNA-based switches of gene expression","volume":"63","author":"Sp\u00f6ring","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms","volume":"35","author":"Steensma","year":"2021","journal-title":"Leukemia"},{"key":"B102","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1142\/9789812704856_0007","article-title":"Transcriptome and genome conservation of alternative splicing events in humans and mice","volume":"2003","author":"Sugnet","year":"2003","journal-title":"Pac Symp. Biocomput"},{"key":"B103","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/371619a0","article-title":"Ribozyme-mediated repair of defective mRNA by targeted trans-splicing","volume":"371","author":"Sullenger","year":"1994","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1038\/s41598-023-31890-4","article-title":"Abnormalities in intron retention characterize patients with systemic lupus erythematosus","volume":"13","author":"Sun","year":"2023","journal-title":"Sci. Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3389\/fgene.2020.00731","article-title":"Innovative therapeutic and delivery approaches using nanotechnology to correct splicing defects underlying disease","volume":"11","author":"Su\u00f1\u00e9-Pou","year":"2020","journal-title":"Front. Genet."},{"key":"B106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/genes8030087","article-title":"Targeting splicing in the treatment of human disease","volume":"8","author":"Su\u00f1\u00e9-Pou","year":"2017","journal-title":"Genes."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","article-title":"Synonymous mutations frequently act as driver mutations in human cancers","volume":"156","author":"Supek","year":"2014","journal-title":"Cell."},{"key":"B108","doi-asserted-by":"publisher","first-page":"20815","DOI":"10.1021\/jacs.2c08770","article-title":"Low-molecular weight small molecules can potently bind RNA and affect oncogenic pathways in cells","volume":"144","author":"Suresh","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"B109","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1073\/pnas.1716617115","article-title":"Intron retention induced by microsatellite expansions as a disease biomarker","volume":"115","author":"Sznajder","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B110","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2010.12.013","article-title":"Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA","volume":"151","author":"Tagami","year":"2011","journal-title":"J. Control. Release"},{"key":"B111","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41525-020-00159-4","article-title":"Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma","volume":"5","author":"Tan","year":"2020","journal-title":"npj Genomic Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/hmg\/ddr094","article-title":"PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa","volume":"20","author":"Tanackovic","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B113","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/emmm.201202303","article-title":"Spliceosome integrity is defective in the motor neuron diseases ALS and SMA","volume":"5","author":"Tsuiji","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/17425247.2019.1663822","article-title":"Recent advances in polymeric materials for the delivery of RNA therapeutics","volume":"16","author":"Ulkoski","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"B115","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/35099500","article-title":"Splicing-related catalysis by protein-free snRNAS","volume":"413","author":"Valadkhan","year":"2001","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1073\/pnas.0902020106","article-title":"Protein-free small nuclear RNAs catalyze a two-step splicing reaction","volume":"106","author":"Valadkhan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1126\/science.1067272","article-title":"Exosome-mediated recognition and degradation of mRNAs lacking a termination codon","volume":"295","author":"Van Hoof","year":"2002","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.semcdb.2017.07.030","article-title":"Challenges in defining the role of intron retention in normal biology and disease","volume":"75","author":"Vanichkina","year":"2018","journal-title":"Seminars Cell. Dev. Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/bies.10153","article-title":"Non-stop decay - a new mRNA surveillance pathway","volume":"24","author":"Vasudevan","year":"2002","journal-title":"BioEssays"},{"key":"B120","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1021\/jacsau.2c00625","article-title":"Chemical RNA cross-linking: mechanisms, computational analysis, and biological applications","volume":"3","author":"Velema","year":"2023","journal-title":"JACS Au"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/nar\/gky062","article-title":"A small, portable RNA device for the control of exon skipping in mammalian cells","volume":"46","author":"Vogel","year":"2018","journal-title":"Nucleic acids Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jid.2012.101","article-title":"Spliceosome-mediated trans-splicing: the therapeutic cut and paste","volume":"132","author":"Wally","year":"2012","journal-title":"J. Investigative Dermatology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1073\/pnas.150104097","article-title":"Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts","volume":"97","author":"Watanabe","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"key":"B125","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41421-019-0109-7","article-title":"Targeted exon skipping with AAV-mediated split adenine base editors","volume":"5","author":"Winter","year":"2019","journal-title":"Cell. Discov."},{"key":"B126","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2013.06.052","article-title":"Orchestrated intron retention regulates normal granulocyte differentiation","volume":"154","author":"Wong","year":"2013","journal-title":"Cell."},{"key":"B127","doi-asserted-by":"publisher","first-page":"115","DOI":"10.26599\/bdma.2022.9020023","article-title":"DeepRetention: a deep learning approach for intron retention detection","volume":"6","author":"Wu","year":"2023","journal-title":"Big Data Min. Anal."},{"key":"B128","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.omtm.2020.04.007","article-title":"Rational design of an activatable reporter for quantitative imaging of RNA aberrant splicing in vivo","volume":"17","author":"Xie","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2174\/1381612821666150531164540","article-title":"Lipid-based nanocarriers for RNA delivery","volume":"21","author":"Xue","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1101\/gad.188037.112","article-title":"Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retention","volume":"26","author":"Yap","year":"2012","journal-title":"Genes. Dev."},{"key":"B131","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1073\/pnas.1406228111","article-title":"RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice","volume":"111","author":"Yasuda","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1073\/pnas.0409742102","article-title":"Identification and analysis of alternative splicing events conserved in human and mouse","volume":"102","author":"Yeo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B133","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1182\/blood.v118.21.458.458","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","article-title":"Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase","volume":"72","author":"Yuan","year":"2018","journal-title":"Mol. Cell."},{"key":"B135","doi-asserted-by":"publisher","first-page":"12392","DOI":"10.1021\/acs.analchem.9b02935","article-title":"Intron retained bioluminescence reporter for real-time imaging of pre-mRNA splicing in living subjects","volume":"91","author":"Zheng","year":"2019","journal-title":"Anal. Chem."},{"key":"B136","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fgene.2020.00586","article-title":"Intron retention as a mode for RNA-seq data analysis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Genet."},{"key":"B137","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1021\/acsabm.9b01131","article-title":"From endocytosis to nonendocytosis: the emerging era of gene delivery","volume":"3","author":"Zhou","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"B138","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-022-05075-2","article-title":"RNA-based therapeutics: an overview and prospectus","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell. death Dis."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1244377\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T08:35:18Z","timestamp":1700210118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2023.1244377\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":138,"alternative-id":["10.3389\/fbioe.2023.1244377"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2023.1244377","relation":{},"ISSN":["2296-4185"],"issn-type":[{"type":"electronic","value":"2296-4185"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"article-number":"1244377"}}